AAPS PharmSci 360 2025

San Antonio, United States | 9 November 2025 - 12 November 2025
Overview

Join us for AAPS 2025 in San Antonio

Our experts will be on hand to discuss your drug development needs and update you on our expanded capabilities.  

Learn how our capabilities are fully integrated with our global drug product and clinical testing capabilities to further streamline your program. 

Dr. Andrew Lewis, our Chief Scientific Officer, will present: Emerging Trends for FIH Studies over the last 4 years and Robert Cornog – Senior Director, Product Development, will present: Translational Pharmaceutics to Support Trials for Orphan/Rare Diseases

Visit our team at Booth 2724 Exhibit Hall 3

You can schedule a partnering meeting with our experts by using the button below.    

Request a meeting with us:
Location
Henry B. Gonzalez Convention Center
900 E Market St, San Antonio, TX 78205
San Antonio, United States

Meet our team

Get your drug development questions answered by our experts and network with our extended team. Stop by and speak with our team at the event. 

Eleanor Row, PhD

VP, Global Commercial - Arcinova

Eleanor Row has over 15 years of experience in the pharmaceutical and contract research environment working with multinational com...

About Eleanor
Jamie Weishaar

VP, Global Commercial Drug Product

Jamie Weishaar is an experienced business development executive leader specializing in pharmaceutical drug development, including ...

About Jamie
Dr. Andrew Lewis

Chief Scientific Officer

Dr. Andrew (Andy) Lewis is the Chief Scientific Officer at Quotient Sciences. As the leader of Quotient Sciences' scientific teams...

About Andrew
Haewon Chong

Director, Business Development - North America - Arcinova

Haewon Chong joined the company in 2025 with extensive experience in technical sales from previous roles at AmbioPharm, Leinco Tec...

About Haewon
Jennifer Lattimer

Executive Director & Head of Global Inside Sales Management

Jennifer Lattimer is a motivated, outgoing and experienced Sales Executive with a demonstrated history of global business closure,...

About Jennifer
Robert Cornog

Senior Director, Product Development

Robert Cornog has over 26 years of experience in product development and process design, across a broad range of dosage forms and ...

About Robert
Alexis Meroney

Associate Director, Business Development

Alexis Meroney drives growth and innovation in the drug development and manufacturing sector, leveraging more than five years of b...

About Alexis
Baleigh Arvanites

Associate Director, Business Development

Baleigh Arvanites is an experienced Business Development professional with a strong background in the CRO/CDMO industry. She began...

About Baleigh

More insight from our experts:

Read More
Drug Product, Commercial Manufacturing, Clinical Trial Manufacturing, Translational Pharmaceutics, Regulatory, Orphan Rare, FDA Navigating Expedited Drug Development Pathways Globally: Q&A with Quotient Sciences Experts
Learn more
Drug Development Consulting, Translational Pharmaceutics, Formulation Development, Drug Product, Careers The Strategic Role of Drug Development Consultants at Quotient Sciences
Learn more
Translational Pharmaceutics, Formulation Development, Peptides, Dr. Andrew Lewis Using a formulation design space with Translational Pharmaceutics® for success in oral peptide development
Learn more
Read More